These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 17003924

  • 1. The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.
    Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, Navis G, Vaughan DE, van Gilst WH, Moore JH.
    Thromb Haemost; 2006 Oct; 96(4):471-7. PubMed ID: 17003924
    [Abstract] [Full Text] [Related]

  • 2. Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.
    Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, Navis G, Vaughan DE, van Gilst WH, Moore JH.
    Genomics; 2007 Mar; 89(3):362-9. PubMed ID: 17207964
    [Abstract] [Full Text] [Related]

  • 3. The effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels are dependent on environmental context.
    Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, Snieder H, Navis G, Vaughan DE, van Gilst WH, Moore JH.
    Hum Genet; 2007 Nov; 122(3-4):275-81. PubMed ID: 17593394
    [Abstract] [Full Text] [Related]

  • 4. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Asselbergs FW, Pattin K, Snieder H, Hillege HL, van Gilst WH, Moore JH.
    Semin Thromb Hemost; 2008 Sep; 34(6):562-8. PubMed ID: 19085655
    [Abstract] [Full Text] [Related]

  • 5. Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population.
    Schoenhard JA, Asselbergs FW, Poku KA, Stocki SA, Gordon S, Vaughan DE, Brown NJ, Moore JH, Williams SM.
    Hum Genet; 2008 Dec; 124(5):479-88. PubMed ID: 18953568
    [Abstract] [Full Text] [Related]

  • 6. Sex differences in the determinants of fibrinolytic activity.
    MacCallum PK, Cooper JA, Howarth DJ, Meade TW, Miller GJ.
    Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046
    [Abstract] [Full Text] [Related]

  • 7. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A.
    Ann Acad Med Stetin; 2005 Mar; 51(1):95-105. PubMed ID: 16496609
    [Abstract] [Full Text] [Related]

  • 8. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC.
    Thromb Res; 2008 Mar; 121(5):675-80. PubMed ID: 17870147
    [Abstract] [Full Text] [Related]

  • 9. A population-based study in Ghana to investigate inter-individual variation in plasma t-PA and PAI-1.
    Williams SM, Stocki S, Jiang L, Brew K, Gordon S, Vaughan DE, Brown NJ, Poku KA, Moore JH.
    Ethn Dis; 2007 Mar; 17(3):492-7. PubMed ID: 17985503
    [Abstract] [Full Text] [Related]

  • 10. [The role of 4G/5G polymorphism in the regulation of plasma levels of PAI-1: a model of interaction between genetic and environmental factors].
    Burzotta F, Di Castelnuovo A, Amore C, D'Orazio A, Donati MB, Iacoviello L.
    Cardiologia; 1998 Jan; 43(1):83-8. PubMed ID: 9534297
    [Abstract] [Full Text] [Related]

  • 11. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 12. Genetic markers of fibrinolytic responses of older persons to exercise training.
    Kulaputana O, Ghiu I, Phares DA, Ferrell RE, Macko RF, Goldberg AP, Hagberg JM.
    Int J Sports Med; 2006 Aug; 27(8):617-22. PubMed ID: 16874588
    [Abstract] [Full Text] [Related]

  • 13. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A.
    Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
    [Abstract] [Full Text] [Related]

  • 14. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M.
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
    Koh SC, Yuen R, Viegas OA, Chua SE, Ng BL, Sen DK, Ratnam SS.
    Thromb Haemost; 1991 Nov 01; 66(5):581-5. PubMed ID: 1803623
    [Abstract] [Full Text] [Related]

  • 16. The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms.
    Moore JH, Smolkin ME, Lamb JM, Brown NJ, Vaughan DE.
    Clin Genet; 2002 Jul 01; 62(1):53-9. PubMed ID: 12123488
    [Abstract] [Full Text] [Related]

  • 17. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.
    van Harmelen V, Wahrenberg H, Eriksson P, Arner P.
    Thromb Haemost; 2000 Feb 01; 83(2):304-8. PubMed ID: 10739390
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population.
    Matsubara Y, Hayakawa T, Tsuda T, Takeshita E, Watanabe G, Murata M, Watanabe K, Ikeda Y.
    Blood Coagul Fibrinolysis; 2000 Mar 01; 11(2):115-20. PubMed ID: 10759003
    [Abstract] [Full Text] [Related]

  • 19. Sequence variants of ACE, AGT, AT1R, and PAI-1 as genetic risk factors for vascular dementia.
    Kim Y, Kim JH, Nam YJ, Kim YJ, Yu KH, Lee BC, Lee C.
    Neurosci Lett; 2006 Jul 03; 401(3):276-9. PubMed ID: 16603315
    [Abstract] [Full Text] [Related]

  • 20. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels.
    Kathiresan S, Gabriel SB, Yang Q, Lochner AL, Larson MG, Levy D, Tofler GH, Hirschhorn JN, O'Donnell CJ.
    Circulation; 2005 Sep 20; 112(12):1728-35. PubMed ID: 16172282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.